Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Carprofen
Norbrook Laboratories Limited
QM01AE91
Carprofen
Solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Cattle
Anti Inflammatory NSAID
Authorized
2009-07-21
Revised: October 2018 AN: 00782/2018 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Carprieve 50mg/ml Solution for Injection for Cattle 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Carprofen 50 mg/ml EXCIPIENTS: Ethanol (anhydrous) 0.1 ml/ml Sodium Formaldehyde Sulphoxylate 2.0 mg/ml For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for Injection. A clear colourless to pale yellow solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Reduction of pyrexia in acute cases of infectious respiratory disease in cattle, in combination with appropriate anti-infective therapy. 4.3 CONTRAINDICATIONS Do not use in animals suffering from cardiac, hepatic or renal impairment. Do not use in animals suffering from gastrointestinal ulceration or bleeding. Do not use where there is evidence of a blood dyscrasia. Do not use in animals with known hypersensitivity to the product. For use in pregnant animals refer to section 4.7. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS Do not exceed the stated dose or the duration of treatment. Revised: October 2018 AN: 00782/2018 Page 2 of 5 Do not administer other NSAIDs concurrently or within 24 hours of each other. Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs, which can lead to toxic effects. Use in any animal less than 6 weeks of age, or in aged animals, may involve additional risk. If such use cannot be avoided animals may require a reduced dosage and careful clinical management. Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of increased renal toxicity. Also refer to section 4.8. II) SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Carprofen, in common with other NSAIDs, has been shown to exhibit photosensitising Read the complete document